# The Medicines (Exemption from Licences) (Clinical Trials) Order 1995, Paragraph 2


A description of each clinical use to be investigated and, in respect of each such use,
(a) the nature and purpose of the clinical trial,
(b) a description of each pharmaceutical form in which the medicinal product is to be administered, and, in respect of each such form, the methods and routes by which the medicinal product is to be administered, the proposed maximum daily dosage and the proposed maximum duration of exposure to the product.

---
Source: https://www.legislation.gov.uk/uksi/1995/2808/schedule/2/paragraph/2 (the official version)
Page: https://openlegislation.uk/medicines-exemption-from-licences-clinical-trials-order-1995/schedule-2/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.